The effect of the vasodilator nicotinamide on cyclic nucleotide pathways in vascular smooth muscle.
Burns
D M
DM
Radiation Science Group, School of Biomedical Sciences, University of Ulster, Newtownabbey, Co. Antrim, N. Ireland.
Ruddock
M W
MW
Brown
J C
JC
Kennovin
G D
GD
Dykes
E L
EL
Flitney
F W
FW
Hirst
D G
DG
D015056:1-Methyl-3-isobutylxanthine / Q000494:pharmacology; D000818:Animals; D001158:Arteries; D000242:Cyclic AMP / Q000378:metabolism*; D006152:Cyclic GMP / Q000378:metabolism*; D004791:Enzyme Inhibitors / Q000494:pharmacology; D007097:Imines / Q000494:pharmacology*; D066298:In Vitro Techniques; D009131:Muscle, Smooth, Vascular / Q000187:drug effects / Q000502:physiology*; D009536:Niacinamide / Q000494:pharmacology*; D010069:Oxadiazoles / Q000494:pharmacology*; D010656:Phenylephrine / Q000494:pharmacology; D010727:Phosphoric Diester Hydrolases / Q000378:metabolism; D011810:Quinoxalines / Q000494:pharmacology*; D051381:Rats; D017208:Rats, Wistar; D015290:Second Messenger Systems; D014664:Vasodilation / Q000187:drug effects; D014665:Vasodilator Agents / Q000494:pharmacology*
C095284:1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one; D004791:Enzyme Inhibitors; D007097:Imines; D010069:Oxadiazoles; D011810:Quinoxalines; D014665:Vasodilator Agents; D010656:Phenylephrine; D009536:Niacinamide; C014925:RMI 12330A; D000242:Cyclic AMP; D010727:Phosphoric Diester Hydrolases; D006152:Cyclic GMP; D015056:1-Methyl-3-isobutylxanthine